TEVA Quote, Financials, Valuation and Earnings

7 Day Trial

ALL ACCESS PASS

7
Get Started

Teva Pharmaceutical Industries Price Quote

$8.45
+0.03 (+0.36%)
(Updated: December 8, 2021 at 5:10 PM ET)

TEVA Key Stats

Score

57
Teva Pharmaceutical Industries (TEVA) is a Buy

Day range:
$8.28 - $8.45
52-week range:
$7.94 - $13.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.57
P/B ratio:
0.89%

Volume:
10.6M
Average volume:
11.9M
1-year change:
-16.3%
Market cap:
$9.3B
Revenue:
$16.7B
EPS:
$0.66

How Much Does Teva Pharmaceutical Industries Make?

Data Unavailable

Is Teva Pharmaceutical Industries Growing As A Company?

  • What Is Teva Pharmaceutical Industries's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.02%
  • What Is Teva Pharmaceutical Industries's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Teva Pharmaceutical Industries Stock Price Performance

  • Did Teva Pharmaceutical Industries Stock Go Up Last Month?
    Teva Pharmaceutical Industries share price went down by -7.78% last month
  • Did TEVA's Share Price Rise Over The Last Year?
    TEVA share price fell by -16.3% over the past 1 year

What Is Teva Pharmaceutical Industries 52 Week High & Low?

  • What Is Teva Pharmaceutical Industries’s 52-week High Share Price?
    Teva Pharmaceutical Industries has traded as high as $13.30 over the past 52 weeks
  • What Is Teva Pharmaceutical Industries’s 52-week Low Share Price?
    Teva Pharmaceutical Industries has traded as low as $7.94 over the past 52 weeks

Teva Pharmaceutical Industries Price To Free Cash Flow

  • Is Teva Pharmaceutical Industries Stock Overvalued?
    Teva Pharmaceutical Industries is trading at a price to free cash flow ratio of 105.73
  • Is Teva Pharmaceutical Industries Stock Undervalued?
    Teva Pharmaceutical Industries EV to Free Cash Flow ratio is 363.33
  • What Is Teva Pharmaceutical Industries’s Price Earnings Growth Ratio?
    TEVA PEG ratio is 0.00
  • Is Teva Pharmaceutical Industries Trading At A Premium To Earnings?
    Teva Pharmaceutical Industries EV to EBIT ratio is 14.94

Is It Risky To Buy Teva Pharmaceutical Industries?

  • How Much Debt Does Teva Pharmaceutical Industries Have?
    Total long term debt quarterly is $23.7B
  • How Much Cash Does Teva Pharmaceutical Industries Have?
    Cash and short term investments quarterly total is $2B
  • What Is Teva Pharmaceutical Industries’s Book Value Per Share?
    Book value per share is 9.49

Is Teva Pharmaceutical Industries Cash Flow Positive?

  • What Is TEVA Cash Flow From Operations?
    Cash flow from operations (TTM) is $673M
  • What Is Teva Pharmaceutical Industries’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.8B
  • What Is Teva Pharmaceutical Industries’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.4B

Teva Pharmaceutical Industries Return On Invested Capital

  • Is Management Doing A Good Job?
    TEVA return on invested capital is 2.01%
  • What Is Teva Pharmaceutical Industries Return On Assets?
    ROA measures how assets are converting to revenues and is 1.47%
  • What Is TEVA Return On Equity?
    ROE is a measure of profitability and is 7.2%

Teva Pharmaceutical Industries Earnings Date & Stock Price

  • What Is Teva Pharmaceutical Industries's Stock Price Today?
    A single share of TEVA can be purchased today for 8.42
  • What Is Teva Pharmaceutical Industries’s Stock Symbol?
    Teva Pharmaceutical Industries trades on the nyse under the ticker symbol: TEVA
  • When Is Teva Pharmaceutical Industries’s Next Earnings Date?
    The next quarterly earnings date for Teva Pharmaceutical Industries is scheduled on February 10, 2022
  • When Is TEVA's next ex-dividend date?
    Teva Pharmaceutical Industries's next ex-dividend date is November 27, 2017
  • How To Buy Teva Pharmaceutical Industries Stock?
    You can buy Teva Pharmaceutical Industries shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Teva Pharmaceutical Industries Competitors

  • Who Are Teva Pharmaceutical Industries's Competitors?
    Below is a list of companies who compete with Teva Pharmaceutical Industries or are related in some way:
    • AbbVie Inc (ABBV)
    • Can Fite Biofarma Ltd (CANF)
    • Compugen Ltd (CGEN)
    • Johnson & Johnson (JNJ)
    • BiomX Inc (PHGE)

Teva Pharmaceutical Industries Dividend Yield

Data Unavailable

Teva Pharmaceutical Industries Analyst Estimates

YoY Growth Past Surprise

EPS
0% -8.65%
Revenue
-2.31% -4.03%

Analyst Recommendations

Buy Recommendations:
1
Hold Recommendations:
15
Sell Recommendations:
0

Price Target:
11.47
Upside from Last Price:
36.24%

Major Shareholders

  • How many TEVA shares are owned by institutional investors?
    895.7M TEVA shares are owned by institutional investors
  • How many TEVA shares are owned by insiders?
    4.4M TEVA shares are owned by insiders